Jump to content

Deborah Zarin

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 14:05, 4 January 2016 (→Bibliography: Journal cites, added 2 PMIDs using AWB (11761)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Deborah Zarin is a scientist at the National Institutes of Health. She is the director of ClinicalTrials.gov.[1]

Zarin has a reputation as an advocate for open data.[2]

In 2014 Zarin accepted a visiting scholar appointment at the Stanford University School of Medicine to research the quality of scientific investigations.[3]

Bibliography

  • Ross, J. S.; Tse, T.; Zarin, D. A.; Xu, H.; Zhou, L.; Krumholz, H. M. (2012). "Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis". BMJ. 344 (jan03 1): d7292 – d7292. doi:10.1136/bmj.d7292. ISSN 0959-8138. PMID 22214755.
  • "Is a Trial For You?", an article from 2005 in The Washington Post
  • Zarin, Deborah A. (2013). "Participant-Level Data and the New Frontier in Trial Transparency". New England Journal of Medicine. 369 (5): 468–469. doi:10.1056/NEJMe1307268. ISSN 0028-4793. PMID 23902488.

References

  1. ^ CHP/PCOR News (February 25, 2009). "Deborah Zarin, Director of ClinicalTrials.gov, addresses CHP/PCOR community". fsi-old.stanford.edu. Retrieved 12 May 2015.
  2. ^ Belluz, Julia (December 6, 2014). "Why it's about to get a lot harder to hide the results of medical studies". Vox. Retrieved 12 May 2015.
  3. ^ staff (April 28, 2014). "Arnold Foundation Awards $6 Million to Boost Quality of Research". philanthropynewsdigest.org. Foundation Center. Retrieved 12 May 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Deborah_Zarin&oldid=698180919"